Similar title :
What to do Before buying should consider Biogen Inc. (NASDAQ: BIIB)
Biogen Inc. (BIIB) is on the advance with an average volume of 1.09 million in the last 3 months
Buy from Biogen Inc. Find the analysis, disclosed market here
Biogen (NASDAQ: BIIB) upgraded to market performance by Raymond James
Cowen is upgrading Biogen (BIIB) to outperformance after receiving FDA approval for Aduhelm